Suppr
超能文献

Advancing Preventive Cardiology: Innovations, Care Pathways, Global Challenges, and the Future of Cardiovascular Health Across the Life Course.

作者信息

Sharma Garima, Spitz Jared A, Mehta Anurag, Shapiro Michael D, Al-Kindi Sadeer

机构信息

Inova Schar Heart and Vascular, Inova Health System, Falls Church, Virginia, USA.

出版信息

JACC Adv. 2025 Jun;4(6 Pt 2):101868. doi: 10.1016/j.jacadv.2025.101868.

DOI:10.1016/j.jacadv.2025.101868

PMID:40579067

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12277616/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ca1/12277616/b1791b7b3e4b/fx1.jpg

相似文献

Advancing Preventive Cardiology: Innovations, Care Pathways, Global Challenges, and the Future of Cardiovascular Health Across the Life Course.

JACC Adv. 2025 Jun;4(6 Pt 2):101868. doi: 10.1016/j.jacadv.2025.101868.

Implementation of prevention guidelines in primary healthcare: a scientific statement of the European Association of Preventive Cardiology of the ESC, the ESC Council for Cardiology Practice, the Association of Cardiovascular Nursing & Allied Professions of the ESC, WONCA Europe, and EURIPA.

Eur J Prev Cardiol. 2025 Jul 17. doi: 10.1093/eurjpc/zwaf384.

Stages and future of women's health: A call for a life-course approach.

Womens Health (Lond). 2025 Jan-Dec;21:17455057251331721. doi: 10.1177/17455057251331721. Epub 2025 Apr 21.

Initiating Preventive Care for Hyperlipidemia in the Emergency Department: The EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders) Trial.

Crit Pathw Cardiol. 2025 Apr 22. doi: 10.1097/HPC.0000000000000390.

Clinical utility and implementation of polygenic risk scores for predicting cardiovascular disease: A clinical consensus statement of the ESC Council on Cardiovascular Genomics, the ESC Cardiovascular Risk Collaboration, and the European Association of Preventive Cardiology.

Eur Heart J. 2025 Apr 15;46(15):1372-1383. doi: 10.1093/eurheartj/ehae649.

Health Technology Assessment and Cardiology: A Review of the Present and Future of Innovation.

J Mark Access Health Policy. 2025 Jun 9;13(2):30. doi: 10.3390/jmahp13020030. eCollection 2025 Jun.

Born Too Soon: learning from the past to accelerate action in the next decade.

Reprod Health. 2025 Jun 23;22(Suppl 2):106. doi: 10.1186/s12978-025-02044-8.

Primary and secondary cardiovascular prevention through life cycles in women. Consensus document of the SEC-GT CVD in Women, ACP-SEC, SEGO, AEEM, SEEN, semFYC, SEMERGEN, AEP, and AEM.

Rev Esp Cardiol (Engl Ed). 2025 Jan 25. doi: 10.1016/j.rec.2025.01.005.

Effective implementation of preventive cardiology guidelines: pathways to success.

Eur J Prev Cardiol. 2025 Jul 18. doi: 10.1093/eurjpc/zwaf448.

Clinical outcome measures in the assessment of impact of pharmacists in cardiology ambulatory care: A systematic review.

Res Social Adm Pharm. 2023 Mar;19(3):432-444. doi: 10.1016/j.sapharm.2022.09.018. Epub 2022 Oct 11.

本文引用的文献

Bridging Genomics to Cardiology Clinical Practice: Artificial Intelligence in Optimizing Polygenic Risk Scores: A Systematic Review.

JACC Adv. 2025 Jun;4(6 Pt 2):101803. doi: 10.1016/j.jacadv.2025.101803.

Gestational Diabetes Mellitus and Heart Failure: A Systematic Review and Meta-Analysis.

JACC Adv. 2025 Jun;4(6 Pt 2):101807. doi: 10.1016/j.jacadv.2025.101807.

The Effect of 12-Week e-Cigarette Use on Smoking Abstinence at 1 Year: The E3 Trial.

JACC Adv. 2025 Jun;4(6 Pt 2):101833. doi: 10.1016/j.jacadv.2025.101833.

Dapagliflozin's Association With Cardiorenal Outcomes and Apolipoprotein M Levels in HFrEF Patients: Insights From DEFINE-HF.

JACC Adv. 2025 Jun;4(6 Pt 2):101800. doi: 10.1016/j.jacadv.2025.101800.

Historical Redlining and Cardio-Kidney-Metabolic Disease Risk Factors, Prevalence, and Outcomes: A Scoping Review.

JACC Adv. 2025 Jun;4(6 Pt 2):101830. doi: 10.1016/j.jacadv.2025.101830.

Prevalence and Mortality Association of Different Stages of Cardiovascular-Kidney-Metabolic Syndrome.

JACC Adv. 2025 Jun;4(6 Pt 2):101843. doi: 10.1016/j.jacadv.2025.101843.

Sociodemographic Disparities in Obesity Prevalence Among Adults Aged 20-59 Years Between 2017 and 2023.

JACC Adv. 2025 Jun;4(6 Pt 2):101798. doi: 10.1016/j.jacadv.2025.101798.

Lipoprotein(a), High-Sensitivity C-Reactive Protein, and All-Cause Mortality in a Primary Prevention Cohort.

JACC Adv. 2025 Jun;4(6 Pt 2):101783. doi: 10.1016/j.jacadv.2025.101783.

A Critical Appraisal of Lipid Management in the Post-Statin Era: Comparison on Guidelines, Therapeutic Targets, and Screening in a Case-Based Framework of Lipid Management.

JACC Adv. 2025 Jun;4(6 Pt 2):101823. doi: 10.1016/j.jacadv.2025.101823.

Sodium-Glucose Cotransporter Inhibition Preserves Apolipoprotein M During Acute Inflammation in Mice and Humans.

JACC Adv. 2025 Jun;4(6 Pt 2):101839. doi: 10.1016/j.jacadv.2025.101839.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

Advancing Preventive Cardiology: Innovations, Care Pathways, Global Challenges, and the Future of Cardiovascular Health Across the Life Course.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译